{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:18:05Z","timestamp":1783491485795,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intravenous thrombolysis with alteplase remains the standard reperfusion strategy for acute ischemic stroke (AIS), yet many patients still experience unfavorable outcomes despite timely treatment, underscoring the need for reliable multimodal prognostic markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify independent clinical, laboratory, and neuroimaging predictors of unfavorable 3-month functional outcome in anterior circulation AIS treated with alteplase, and to develop, internally validate, and benchmark an integrated multivariable model in accordance with TRIPOD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective single-center cohort study enrolled 268 consecutive patients with anterior circulation AIS receiving intravenous alteplase within 4.5 h of symptom onset (March 2022\u2013February 2025). Three-month outcome was assessed by the modified Rankin Scale (mRS 0\u20132 favorable; 3\u20136 unfavorable) using validated structured instruments administered by blinded raters. Multivariable logistic regression was performed, and the final model was internally validated by 1,000-replicate bootstrap with optimism correction and shrinkage, evaluated by decision curve analysis (DCA), rendered into a nomogram, and benchmarked head-to-head against three previously published reference models using the DeLong test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 268 patients, 99 (36.9%) experienced unfavorable outcomes. Seven independent predictors were identified: early neurological deterioration (adjusted OR 3.45, 95% CI 2.01\u20135.92), large infarction exceeding one-third of the middle cerebral artery territory (OR 2.78, 1.58\u20134.89), baseline NIHSS (OR 1.14 per point, 1.07\u20131.22), poor Tan collateral score (OR 2.31, 1.34\u20133.98), low clot burden score (OR 2.15, 1.28\u20133.61), elevated D-dimer (OR 2.19, 1.29\u20133.72), and elevated CRP (OR 1.87, 1.11\u20133.15). The model achieved an apparent AUC of 0.847 (95% CI 0.801\u20130.893) and an optimism-corrected AUC of 0.831 (0.785\u20130.877) on bootstrap validation, with satisfactory calibration (Hosmer\u2013Lemeshow\n                      <jats:italic>P<\/jats:italic>\n                      = 0.394). DCA showed positive net benefit across threshold probabilities of 0.15\u20130.75, and the model exceeded the recalibrated Hu, Ping, and Lv models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A multimodal panel integrating clinical, inflammatory, coagulation, and neuroimaging parameters independently predicts unfavorable 3-month outcome following intravenous thrombolysis in anterior circulation AIS. The findings are hypothesis-generating pending external validation in independent multicenter cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2026.1818367","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:53:53Z","timestamp":1783490033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of unfavorable 3-month functional outcome following intravenous thrombolysis with alteplase in anterior circulation acute ischemic stroke: a prospective cohort study"],"prefix":"10.3389","volume":"20","author":[{"given":"Chaowei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Henan Medical University, Weihui","place":["Henan, China"]},{"name":"Henan Key Laboratory of Neural Repair and Protein Modification, Henan International Joint Laboratory for Neural Repair of Alzheimer\u2019s Disease, Henan Engineering Research Center for Neural Repair, Henan Engineering and Technology Research Center for Neural Repair, Henan Key Medical Laboratory of Neurology","place":["Xinxiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Henan Medical University, Weihui","place":["Henan, China"]},{"name":"Henan Key Laboratory of Neural Repair and Protein Modification, Henan International Joint Laboratory for Neural Repair of Alzheimer\u2019s Disease, Henan Engineering Research Center for Neural Repair, Henan Engineering and Technology Research Center for Neural Repair, Henan Key Medical Laboratory of Neurology","place":["Xinxiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Mao","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Neural Repair and Protein Modification, Henan International Joint Laboratory for Neural Repair of Alzheimer\u2019s Disease, Henan Engineering Research Center for Neural Repair, Henan Engineering and Technology Research Center for Neural Repair, Henan Key Medical Laboratory of Neurology","place":["Xinxiang, China"]},{"name":"Department of Neuroelectrophysiology, First Affiliated Hospital of Henan Medical University, Weihui","place":["Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Henan Medical University, Weihui","place":["Henan, China"]},{"name":"Henan Key Laboratory of Neural Repair and Protein Modification, Henan International Joint Laboratory for Neural Repair of Alzheimer\u2019s Disease, Henan Engineering Research Center for Neural Repair, Henan Engineering and Technology Research Center for Neural Repair, Henan Key Medical Laboratory of Neurology","place":["Xinxiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yao","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Neural Repair and Protein Modification, Henan International Joint Laboratory for Neural Repair of Alzheimer\u2019s Disease, Henan Engineering Research Center for Neural Repair, Henan Engineering and Technology Research Center for Neural Repair, Henan Key Medical Laboratory of Neurology","place":["Xinxiang, China"]},{"name":"Department of Mathematics and Statistics, Xinxiang University, Xinxiang","place":["Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e001574","DOI":"10.1161\/SVIN.124.001574","article-title":"Association of fibrinolysis with acute ischemic stroke outcome in patients undergoing thrombectomy: Modification by additional administration of tPA?","volume":"5","author":"Barakzie","year":"2025","journal-title":"Stroke Vasc. Interv. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.","volume":"6","author":"Berge","year":"2021","journal-title":"Eur. Stroke J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.111.613273","article-title":"Simplified modified Rankin Scale questionnaire: Reproducibility over the telephone and validation with quality of life.","volume":"42","author":"Bruno","year":"2011","journal-title":"Stroke"},{"key":"B4","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement.","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials.","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","article-title":"World Stroke Organization (WSO): Global stroke fact sheet 2022.","volume":"17","author":"Feigin","year":"2022","journal-title":"Int. J. Stroke"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1080046","DOI":"10.3389\/fneur.2023.1080046","article-title":"Predictors and long-term outcome of intracranial hemorrhage after thrombolytic therapy for acute ischemic stroke: A prospective single-center study.","volume":"14","author":"Fekete","year":"2023","journal-title":"Front. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019.","volume":"20","year":"2021","journal-title":"Lancet Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e14748","DOI":"10.1111\/cns.14748","article-title":"Cerebral autoregulation: A reliable predictor of prognosis in patients receiving intravenous thrombolysis.","volume":"30","author":"Guo","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3363735","DOI":"10.1155\/2022\/3363735","article-title":"Influence factors and predictive models for the outcome of patients with ischemic stroke after intravenous thrombolysis: a multicenter retrospective cohort study","volume":"2022","author":"Hu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.2147\/NDT.S389469","article-title":"Post-thrombolytic D-dimer elevation predicts symptomatic intracranial hemorrhage and poor functional outcome after intravenous thrombolysis in acute ischemic stroke patients.","volume":"18","author":"Jin","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10760296221121287","DOI":"10.1177\/10760296221121287","article-title":"Clinical significance and dynamic change of coagulation parameters in ischemic stroke patients treated with intravenous thrombolysis.","volume":"28","author":"Li","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"B14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12974-023-02758-1","article-title":"Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: A prospective cohort study.","volume":"20","author":"Li","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e6021","DOI":"10.7717\/peerj.6021","article-title":"Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke.","volume":"6","author":"Lin","year":"2018","journal-title":"PeerJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1756286420953054","DOI":"10.1177\/1756286420953054","article-title":"Early prediction of the 3-month outcome for individual acute ischemic stroke patients who received intravenous thrombolysis using the N2H3 nomogram model.","volume":"13","author":"Lv","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1161\/STROKEAHA.109.552513","article-title":"Collateral vessels on CT angiography predict outcome in acute ischemic stroke.","volume":"40","author":"Maas","year":"2009","journal-title":"Stroke"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3174\/ajnr.A2564","article-title":"Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions.","volume":"32","author":"Menon","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1017883","DOI":"10.3389\/fnins.2022.1017883","article-title":"Prognostic nomogram for the outcomes in acute stroke patients with intravenous thrombolysis.","volume":"16","author":"Ping","year":"2022","journal-title":"Front. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"B21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1747-4949.2008.00221.x","article-title":"Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score","volume":"3","author":"Puetz","year":"2008","journal-title":"Int. J. Stroke"},{"key":"B22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/STROKEAHA.109.571364","article-title":"Improving the reliability of stroke disability grading in clinical trials and clinical practice: The Rankin Focused Assessment (RFA).","volume":"41","author":"Saver","year":"2010","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/jnnp-2014-308327","article-title":"Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: A systematic review with pathophysiological implications.","volume":"86","author":"Seners","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1161\/STROKEAHA.119.026139","article-title":"Heart failure in ischemic stroke: Relevance for acute care and outcome.","volume":"50","author":"Siedler","year":"2019","journal-title":"Stroke"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0254253","DOI":"10.1371\/journal.pone.0254253","article-title":"Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.","volume":"16","author":"Szegedi","year":"2021","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3174\/ajnr.A1408","article-title":"CT angiography clot burden score and collateral score: Correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct.","volume":"30","author":"Tan","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jocn.2013.06.015","article-title":"C-reactive protein and long-term ischemic stroke prognosis.","volume":"21","author":"VanGilder","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: A novel method for evaluating prediction models.","volume":"26","author":"Vickers","year":"2006","journal-title":"Med. Decis. Making"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s10072-024-07329-7","article-title":"Development and validation of outcome prediction model for reperfusion therapy in acute ischemic stroke using nomogram and machine learning.","volume":"45","author":"Wang","year":"2024","journal-title":"Neurol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1161\/STROKEAHA.107.504498","article-title":"Associations of proinflammatory cytokines with the risk of recurrent stroke.","volume":"39","author":"Welsh","year":"2008","journal-title":"Stroke"},{"key":"B31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/02841851231218375","article-title":"Could emergency admission plasma D-dimer level predict first pass effect of stent retriever thrombectomy in acute ischemic stroke?","volume":"65","author":"Xie","year":"2024","journal-title":"Acta Radiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.21037\/atm-21-40","article-title":"Intravenous thrombolysis in Chinese patients with mild acute ischemic stroke.","volume":"9","author":"Xiong","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12959-025-00704-0","article-title":"Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: A retrospective cohort study.","volume":"23","author":"Xu","year":"2025","journal-title":"Thromb. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10760296231187616","DOI":"10.1177\/10760296231187616","article-title":"Determinants of 1-year unfavorable outcomes of intravenous alteplase thrombolysis for acute ischemic stroke.","volume":"29","author":"Zhai","year":"2023","journal-title":"Clin. Appl. Thromb. Hemost."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1818367\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:53:56Z","timestamp":1783490036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1818367\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":34,"alternative-id":["10.3389\/fnins.2026.1818367"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1818367","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1818367"}}